Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002594638 | SCV002949511 | pathogenic | not provided | 2022-10-26 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asp73Argfs*11) in the SLC18A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC18A2 are known to be pathogenic (PMID: 26539891, 31618753). This variant is present in population databases (no rsID available, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with SLC18A2-related conditions. For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV004577023 | SCV004175905 | pathogenic | Brain dopamine-serotonin vesicular transport disease | 2023-12-11 | no assertion criteria provided | literature only |